PUBLISHER: IMARC | PRODUCT CODE: 1423294
PUBLISHER: IMARC | PRODUCT CODE: 1423294
Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2024-2032
Abstract
The Brazil generic drug market size reached US$ 21.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
Since the introduction of generic drugs in 2001, Brazil's pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market in the coming years.
The report entitled "Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2024-2032" represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Key Questions Answered in this Report:
What are generic drugs, how are they different from branded drugs?
How has the generic drug market performed in recent years?
How have generics performed compared to branded drugs?
What were the total sales and volumes of generic drugs in Brazil?
What has been the impact of COVID-19 on the Brazil generic drug industry?
Who are the key players in Brazil generic drug market?
What is the structure of the generic drug market in Brazil?
What is the pricing mechanism of generic drugs in Brazil?
What is the value chain of generic drugs in Brazil?
What are the regulations for generic drugs in Brazil?
How are generic drugs distributed in Brazil?
How are generic drugs manufactured?
What are the drivers and challenges in the generic drugs market in Brazil?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Brazil Generic Drug Market - Introduction
- 4.1 What are Generic Drugs?
- 4.2 Classification of Generic Drugs
5 Why is the Brazil Generic Drug Market So Lucrative
- 5.1 Drug Patent Expiries
- 5.2 Lower Costs
- 5.3 Government Support
- 5.4 Increasing Consumer Confidence
- 5.5 Increasing Access to Generic Drugs
- 5.6 High Growth Potential for Biosimilar Drugs
6 Global Generic Drug Market
- 6.1 Generic Drug Market Performance
- 6.1.1 Value Trends
- 6.1.2 Volume Trends
- 6.2 Market Breakup by Country
- 6.3 Most Prescribed Generic and Branded Drugs
- 6.4 Market Forecast
7 Brazil Generic Drug Market
- 7.1 Brazil Pharmaceutical Market Performance
- 7.1.1 Value Trends
- 7.1.2 Volume Trends
- 7.1.3 Market Breakup by Type
- 7.1.4 Market Forecast
- 7.2 Brazil Generic Drug Market Performance
- 7.2.1 Value Trends
- 7.2.2 Volume Trends
- 7.2.3 Impact of COVID-19
- 7.2.4 Market Forecast
8 Brazil Generic Drug Industry: SWOT Analysis
- 8.1 Overview
- 8.2 Strengths
- 8.3 Weaknesses
- 8.4 Opportunities
- 8.5 Threats
9 Brazil Generic Drug Industry: Value Chain Analysis
- 9.1 Research and Development
- 9.2 Manufacturing
- 9.3 Marketing
- 9.4 Distribution
- 9.5 Pricing
10 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain
11 Brazil Generic Drug Industry: Porter's Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Brazil Generic Drug Market: Competitive Landscape
- 12.1 Brazil Generic Drug Market: Competitive Structure
- 12.2 Brazil Generic Drug Market: Market Share of Key Players
- 12.3 Distribution Channels
13 Government Policy
14 Brazil Generic Drug Market: Key Success Factors
15 Brazil Generic Drug Market: Road Blocks
16 Generic Drug Manufacturing Process
- 16.1 Manufacturing Process
- 16.2 Raw Material Requirements
- 16.3 Raw Materials Pictures
- 16.4 Land and Construction Requirements
- 16.5 Machinery and Infrastructure Requirements
- 16.6 Machinery Pictures
- 16.7 Plant Layout
- 16.8 Packaging Requirements
- 16.9 Utility Requirements
- 16.10 Manpower Requirements
17 Brazil Generic Drug Market: Key Company Profiles
List of Figures
- Figure 1: Structure of the Pharmaceutical Industry
- Figure 2: Classification of Drugs
- Figure 3: Global: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
- Figure 4: Global: Generic Drug Market: Sales Volume (in Billion Units), 2018-2023
- Figure 5: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2023
- Figure 6: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2023
- Figure 7: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 8: Global: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2024-2032
- Figure 9: Brazil: Pharmaceutical Market: Sales Value (in Billion US$), 2018-2023
- Figure 10: Brazil: Pharmaceutical Market: Sales Volume (in Billion Units), 2018-2023
- Figure 11: Brazil: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 12: Brazil: Pharmaceutical Market Forecast: Sales Volume (in Billion Units), 2024-2032
- Figure 13: Brazil: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2018 and 2023
- Figure 14: Brazil: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2018 and 2023
- Figure 15: Brazil: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
- Figure 16: Brazil: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 17: Brazil: Generic Drug Market: Sales Volume (in Billion Units), 2018-2023
- Figure 18: Brazil: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2024-2032
- Figure 19: Brazil: Generic Drug Industry: SWOT Analysis
- Figure 20: Brazil: Generic Drug Industry: Value Chain Analysis
- Figure 21: Brazil: Pricing Trends and Profit Margins at Various Levels of Supply Chain
- Figure 22: Brazil: Generic Drug Industry: Porter's Five Forces Analysis
- Figure 23: Brazil: Generic Drug Market: Sales Share of Top Players (in %)
- Figure 24: Brazil: Generic Drug Market: Number of Companies Producing Generic Drugs (in Units), 2015
- Figure 25: Brazil: Number of Pharmacies and Drug Stores, 2015
- Figure 26: Brazil: Region-Wise Drug Sales Value (in %), 2015
- Figure 27: Brazil: Channel-Wise Market Share by Number of Stores, 2015
- Figure 28: Brazil: Channel-Wise Market Share by Sales Value (in %), 2015
- Figure 29: Generic Drug Manufacturing: Detailed Process Flow
- Figure 30: Generic Drug Manufacturing: Plant Layout
- Figure 31: Generic Drug Manufacturing: Packaging Requirements
List of Tables
- Table 1: Brazil: Sales (in Billion US$) and Patent Expiry of Major Drugs Expected to Lose Patent Protection
- Table 2: Generic Drug Manufacturing Plant: Raw Material Requirements
- Table 3: Generic Drug Manufacturing Plant: Land and Construction Requirements
- Table 4: Generic Drug Manufacturing Plant: Machinery Requirements
- Table 5: Generic Drug Manufacturing Plant: Utility Requirements
- Table 6: Generic Drug Manufacturing Plant: Manpower Requirements
